查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586417

类器官和球体市场、占有率、规模、趋势、行业分析报告：按类型、按应用、按最终用途、按地区、按细分市场、预测，2024-2032 年

Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球类器官和球体市场规模预计将达到 51.1759 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

CRISPR/Cas-9等基因编辑技术的发展使研究人员能够对干细胞基因进行精确的改变，从而产生模仿疾病状态的类器官和球体。这些进展为复杂的细胞状态提供了宝贵的见解，并为研究人员提供了疾病研究和药物测试的改进模型。干细胞技术和 3D 培养方法的进步相结合，在类器官和球体市场的稳定成长中发挥关键作用。2024 年 1 月，南加州大学USC研究人员开发了一种新的人类大脑类器官模型，用于研究小脑发育和神经系统疾病中小脑病理的出现。

患者特异性类器官代表了推进个人化医疗的强大平台，并透过对从患者身上采集的组织进行潜在药物测试，正在推动类器官和球体市场的成长。类器官和球体在研究和临床环境中的临床重要性对于开发个人化类器官模型和促进 P4 医学的进步至关重要。

3D生物列印技术和器官晶片平台的发展将大大推进类器官和球体的研究。3D 生物列印能够创建高精度的复杂、客製化的组织模型，从而增强药物测试和个人化医疗。器官晶片平台以微型方式重建器官功能，从而实现动态建模、高通量筛选和个人化治疗策略。这些创新提高了生物医学研究的准确性和相关性，促进更有效的药物开发和疾病理解。

类器官和球体市场报告亮点

按类型划分，球体部分由于其在药物发现和疾病建模中的重要应用，将在 2023 年占据主要占有率。

由于癌症、神经退化性疾病和传染病等疾病的发生率不断增加以及对先进研究模型的需求不断增长，预计类器官领域将在预测期内快速增长。

从应用来看，发育生物学领域因其在器官形成机制的应用而在 2023 年占据市场主导地位。

由于类器官和球体越来越多地用于个人化医疗，北美将在 2023 年占据最大占有率。

主要公司包括 3D Biomatrix、3D Biotek、AMS Biotechnology、Cellsce、Greiner Bio-One 和 Thermo Fisher Scientific。

目录

第1章简介

第2章 执行摘要

第3章 研究方法

第4章全球类器官与球体市场洞察

  • 市场快照
  • 类器官和球体市场动态
    • 驱动因素和机遇
      • 干细胞研究进展
      • 扩大药物发现和个人化医疗的应用
    • 限制因素和课题
      • 开发和生产成本高
  • PESTEL 分析
  • 类器官和球体市场应用趋势
  • 价值链分析
  • COVID-19 影响分析

第5章全球类器官和球体市场：按类型

  • 主要发现
  • 介绍
  • 类器官
  • 球体

第6章全球类器官与球体市场：依应用分类

  • 主要发现
  • 介绍
  • 发育生物学
  • 个人化医疗
  • 再生医学
  • 疾病病理学研究
  • 药物毒性及药效测试

第7章全球类器官和球体市场：依最终用途分类

  • 主要发现
  • 介绍
  • 生物技术和製药业
  • 学术研究机构
  • 医院和诊断中心

第8章全球类器官和球体市场：按地区

  • 主要发现
  • 介绍
    • 类器官和球体市场评估：地区，2019-2032
  • 北美
    • 北美：按类型划分，2019-2032
    • 北美：依申请划分，2019-2032
    • 北美：依最终用途分类，2019-2032
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依类型划分，2019-2032
    • 欧洲：依申请划分，2019-2032
    • 欧洲：依最终用途分类，2019-2032
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 亚太地区：依类型划分，2019-2032
    • 亚太地区：依应用划分，2019-2032
    • 亚太地区：依最终用途分类，2019-2032
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 中东/非洲
    • 中东和非洲：按类型划分，2019-2032
    • 中东和非洲：依申请划分，2019-2032
    • 中东和非洲：依最终用途分类，2019-2032
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
    • 其他中东/非洲
  • 拉丁美洲
    • 拉丁美洲：按类型划分，2019-2032
    • 拉丁美洲：按应用划分，2019-2032
    • 拉丁美洲：依最终用途分类，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第9章竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章 公司简介

  • 3D Biomatrix
  • 3D Biotek LLC
  • AMS Biotechnology Limited
  • Cellesce Ltd.
  • TheWell Bioscience
  • Greiner Bio-One
  • Hubrecht Organoid Technology（HUB）
  • InSphero
  • Lonza
  • Merck KGaA
  • Prellis Biologics
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: PM1782

The global organoids and spheroids market size is expected to reach USD 5,117.59 million by 2032, according to a new study by Polaris Market Research. The report "Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type, Application, End Use, and Region; Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.

Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.

The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.

Organoids and Spheroids Market Report Highlights

Based on type, the spheroids segment held a larger share in 2023, owing to their significant use in drug discovery and disease modeling.

The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.

By application, the developmental biology segment dominated the market in 2023, owing to its application in the mechanism of organogenesis.

North America holds the largest share in 2023, owing to the rising use of organoids and spheroids for personalized medicine.

A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD million, 2019-2032)

  • Organoids
  • By Type
  • Neural Organoids
  • Hepatic Organoids
  • Intestinal Organoids
  • Other Organoids
  • By Method
  • General Submerged Method for Organoid Culture
  • Crypt Organoid Culture Techniques
  • Air Liquid Interface (ALI) Method for Organoid Culture
  • Clonal Organoids from Lgr5+ Cells
  • Brain and Retina Organoid Formation Protocol
  • Others
  • By Source
  • Primary Tissues
  • Stem Cells
  • Spheroids
  • By Type
  • Multicellular Tumor Spheroids (MCTS)
  • Neurospheres
  • Mammospheres
  • Hepatospheres
  • Embryoid Bodies
  • By Method
  • Micropatterned Plates
  • Low Cell Attachment Plates
  • Hanging Drop Method
  • Others
  • By Source
  • Cell Line
  • Primary Cell
  • iPSCs Derived Cells

By Application Outlook (Revenue - USD million, 2019-2032)

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

By End Use Outlook (Revenue - USD million, 2019-2032)

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

By Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Organoids and Spheroids Market Insights

  • 4.1. Organoids and Spheroids Market - Market Snapshot
  • 4.2. Organoids and Spheroids Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancement in stem cell research
      • 4.2.1.2. Increased application in drug discovery and personalized medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of development and Production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Organoids and Spheroids Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Organoids and Spheroids Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • 5.3. Organoids
    • 5.3.1. Global Organoids and Spheroids Market, by Organoids, by Region, 2019-2032 (USD Million)
  • 5.4. Spheroids
    • 5.4.1. Global Organoids and Spheroids Market, by Spheroids, by Region, 2019-2032 (USD Million)

6. Global Organoids and Spheroids Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • 6.3. Developmental Biology
    • 6.3.1. Global Organoids and Spheroids Market, by Developmental Biology, by Region, 2019-2032 (USD Million)
  • 6.4. Personalized Medicine
    • 6.4.1. Global Organoids and Spheroids Market, by Personalized Medicine, by Region, 2019-2032 (USD Million)
  • 6.5. Regenerative Medicine
    • 6.5.1. Global Organoids and Spheroids Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)
  • 6.6. Disease Pathology Studies
    • 6.6.1. Global Organoids and Spheroids Market, by Disease Pathology Studies, by Region, 2019-2032 (USD Million)
  • 6.7. Drug Toxicity & Efficacy Testing
    • 6.7.1. Global Organoids and Spheroids Market, by Drug Toxicity & Efficacy Testing, by Region, 2019-2032 (USD Million)

7. Global Organoids and Spheroids Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 7.3. Biotechnology & Pharmaceutical Industries
    • 7.3.1. Global Organoids and Spheroids Market, by Biotechnology & Pharmaceutical Industries, by Region, 2019-2032 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Global Organoids and Spheroids Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Million)
  • 7.5. Hospitals & Diagnostic Centers
    • 7.5.1. Global Organoids and Spheroids Market, by Hospitals & Diagnostic Centers, by Region, 2019-2032 (USD Million)

8. Global Organoids and Spheroids Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Organoids and Spheroids Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Organoids and Spheroids Market - North America
    • 8.3.1. North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.3.3. North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.4. Organoids and Spheroids Market - U.S.
      • 8.3.4.1. U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.3.5. Organoids and Spheroids Market - Canada
      • 8.3.5.1. Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.4. Organoids and Spheroids Market - Europe
    • 8.4.1. Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.4.3. Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.4. Organoids and Spheroids Market - UK
      • 8.4.4.1. UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.5. Organoids and Spheroids Market - France
      • 8.4.5.1. France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.3. France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.6. Organoids and Spheroids Market - Germany
      • 8.4.6.1. Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.7. Organoids and Spheroids Market - Italy
      • 8.4.7.1. Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.8. Organoids and Spheroids Market - Spain
      • 8.4.8.1. Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.9. Organoids and Spheroids Market - Netherlands
      • 8.4.9.1. Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.10. Organoids and Spheroids Market - Russia
      • 8.4.10.1. Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.4.11. Organoids and Spheroids Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.4.11.2. Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.4.11.3. Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.5. Organoids and Spheroids Market - Asia Pacific
    • 8.5.1. Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.4. Organoids and Spheroids Market - China
      • 8.5.4.1. China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.3. China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.5. Organoids and Spheroids Market - India
      • 8.5.5.1. India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.3. India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.6. Organoids and Spheroids Market - Malaysia
      • 8.5.6.1. Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.7. Organoids and Spheroids Market - Japan
      • 8.5.7.1. Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.8. Organoids and Spheroids Market - Indonesia
      • 8.5.8.1. Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.9. Organoids and Spheroids Market - South Korea
      • 8.5.9.1. South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.10. Organoids and Spheroids Market - Australia
      • 8.5.10.1. Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.10.2. Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.10.3. Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.5.11. Organoids and Spheroids Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.6. Organoids and Spheroids Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.4. Organoids and Spheroids Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.5. Organoids and Spheroids Market - UAE
      • 8.6.5.1. UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.6. Organoids and Spheroids Market - Israel
      • 8.6.6.1. Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.7. Organoids and Spheroids Market - South Africa
      • 8.6.7.1. South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.6.8. Organoids and Spheroids Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • 8.7. Organoids and Spheroids Market - Latin America
    • 8.7.1. Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.4. Organoids and Spheroids Market - Mexico
      • 8.7.4.1. Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.5. Organoids and Spheroids Market - Brazil
      • 8.7.5.1. Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.6. Organoids and Spheroids Market - Argentina
      • 8.7.6.1. Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
    • 8.7.7. Organoids and Spheroids Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
      • 8.7.7.2. Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
      • 8.7.7.3. Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. 3D Biomatrix
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Type Benchmarking
    • 10.1.4. Recent Development
  • 10.2. 3D Biotek LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Type Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AMS Biotechnology Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Type Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cellesce Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Type Benchmarking
    • 10.4.4. Recent Development
  • 10.5. TheWell Bioscience
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Type Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Greiner Bio-One
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Type Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hubrecht Organoid Technology (HUB)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Type Benchmarking
    • 10.7.4. Recent Development
  • 10.8. InSphero
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Type Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Lonza
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Type Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck KGaA
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Type Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Prellis Biologics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Type Benchmarking
    • 10.11.4. Recent Development
  • 10.12. STEMCELL Technologies Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Type Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Thermo Fisher Scientific, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Type Benchmarking
    • 10.13.4. Recent Development

List of Tables:

  • Table 1 Global Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 4 North America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 5 North America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 6 North America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 7 U.S.: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 8 U.S.: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 9 U.S.: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 10 Canada: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 11 Canada: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 12 Canada: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 13 Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 14 Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 15 Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 16 UK: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 17 UK: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 18 UK: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 19 France: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 20 France: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 21 France: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 22 Germany: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 23 Germany: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 25 Italy: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 26 Italy: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 27 Italy: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 28 Spain: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 29 Spain: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 30 Spain: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 31 Netherlands: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 32 Netherlands: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 33 Netherlands: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 34 Russia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 35 Russia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 36 Russia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 37 Rest of Europe: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 38 Rest of Europe: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 39 Rest of Europe: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 41 Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 42 Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 43 China: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 44 China: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 45 China: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 46 India: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 47 India: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 48 India: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 49 Malaysia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 50 Malaysia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 51 Malaysia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 52 Japan: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 53 Japan: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 54 Japan: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 55 Indonesia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 56 Indonesia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 57 Indonesia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 58 South Korea: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 59 South Korea: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 60 South Korea: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 61 Australia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 62 Australia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 63 Australia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 64 Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 65 Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 66 Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 67 Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 68 Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 69 Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 70 Saudi Arabia: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 71 Saudi Arabia: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 72 Saudi Arabia: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 73 UAE: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 74 UAE: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 75 UAE: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 76 Israel: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 77 Israel: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 78 Israel: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 79 South Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 80 South Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 81 South Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 82 Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 83 Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 84 Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 85 Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 86 Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 87 Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 88 Mexico: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 89 Mexico: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 90 Mexico: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 91 Brazil: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 92 Brazil: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 93 Brazil: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 94 Argentina: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 95 Argentina: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 96 Argentina: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • Table 97 Rest of Latin America: Organoids and Spheroids Market, by Type, 2019-2032 (USD Million)
  • Table 98 Rest of Latin America: Organoids and Spheroids Market, by Application, 2019-2032 (USD Million)
  • Table 99 Rest of Latin America: Organoids and Spheroids Market, by End Use, 2019-2032 (USD Million)
  • List of Figures:
  • Figure 1. Global Organoids and Spheroids Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Organoids and Spheroids Market, by Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Organoids and Spheroids Market, by Application, 2023 & 2032 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Organoids and Spheroids Market, by End Use, 2023 & 2032 (USD Million)